Show items per page
Elements: 9
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Functional imaging markers of the MCI brain in task and at rest: detecting memory and connectivity impairments in prodromal Alzheimer's disease Kebets, Valeria 2016
add to browser selection
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study' PharmaCog Consortium 2016
add to browser selection
Contribution of electro-cortical imaging to neuroscience of aging and cognitive decline Deiber Ibanez, Marie-Pierre 2017
add to browser selection
ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study Mauthner, Oliver; Claes, Veerle; Walston, Jeremy; Engberg, Sandra; ... De Geest, Sabina 2017
add to browser selection
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease Collaboration 2018
add to browser selection
AMYPAD Diagnostic and Patient Management Study: Rationale and design Frisoni, Giovanni; Barkhof, Frederik; Canzoneri, Elisa 2018
add to browser selection
Multivariate and predictive modelling of neural variability in mild cognitive impairment Kebets, Valeria; Van Assche, Mitsouko; Richiardi, Jonas; Goldstein, Rachel; ... Van De Ville, Dimitri 2018
add to browser selection
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers The PharmaCog Consortium 2019
add to browser selection
Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features Low, Audrey; Mak, Elijah; Malpetti, Maura; Chouliaras, Leonidas; ... O'Brien, John T. 2019